Professor Salvare and Pete Paystoomuch watch government, the private sector, universities, and foundations pass the baton in a research relay race that is ultimately anchored by private companies that finish the race to develop new medicines that treat illnesses and create cures for devastating diseases....
PRI President, CEO, and Thomas W. Smith Fellow in Health Care Studies Sally C. Pipes joins PRI's Next Round podcast to discuss some of the health care challenges that have popped up during the coronavirus crisis, including a renewed push for single-payer and calls for prescription drug price controls and a “Buy America” mandate for drug manufacturing. We also discuss a few positives changes that have occurred despite these tough times – the rise of telehealth and the rolling back...
As Americans endure the privations necessary to “flatten the curve” of new cases of coronavirus COVID-19, we wish that our leaders could manage even a fraction of the comity and tolerance exhibited every day by ordinary people throughout this country. Sadly, we see too much of the opposite. Putting aside the machinations of politicians, there seems to be a widespread need to blame any misstep, or even uncertainty, on somebody or something. The ubiquitousness of social media and the internet drives the...
PRI Senior Fellow in Health Care Studies Dr. Henry Miller joins PRI's Next Round podcast with an update on the fight against the coronavirus. He offers much-needed perspective on what public health officials are doing to “flatten the curve,” efforts to find vaccines and treatments, the efforts of other countries to contain the virus, when we can expect to get back to business as usual, and whether we should expect more viruses like these going forward. https://youtu.be/1FlElnaB3Ps...
The federal government’s efforts to combat the ongoing coronavirus pandemic illustrate why we shouldn’t put our full trust in government to find a cure. After all, they badly botched the testing, costing valuable time in identifying new cases and limiting its spread. Fortunately, private-sector innovators are leading where government has underwhelmed, conducting speedy research and development into potentially life-saving cures, while providing critical support in other areas where government action was lacking. The first version of test kits from the Centers for...
Title: COVID-19 Pandemic Delaying Treatments of Hematologic Cancers By: John Schieszer Institutional restrictions due to the coronavirus disease 2019 (COVID-19) pandemic are taking a large toll on patients with hematologic cancers. Some medical centers have canceled treatments and all centers have altered their policies and procedures. Starting in March, elective and semielective surgical procedures at most hospitals throughout the United States were put on hold, and uncertainty remains regarding when these procedures will start up again. . . . . . Because there is...
Kirby’s guest is Sally C. Pipes-she is President, CEO, and Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute, a San Francisco-based think tank founded in 1979. Prior to becoming president of PRI in 1991, she was assistant director of the Fraser Institute, based in Vancouver, Canada. Click here to listen to the interview. ...
Watch Dr. Wayne Winegarden, director of PRI's Center for Medical Economics and Innovation, discuss the issues and benefits of the FDA's switch to a biologics regulatory pathway for certain products, especially insulin, during the World Biosimilar Congress USA 2020 at the Festival of Biologics USA in San Diego, California. https://youtu.be/XOk2V13Hyrk...
SAN FRANCISCO – As prescription drug pricing and accessibility has become a greater topic of discussion during the current coronavirus pandemic, a new series of animated videos launched today by the Center for Medical Economics and Innovation at the Pacific Research Institute aims to guide Americans through the “drug pricing maze”. The new series will educate viewers on how the current drug pricing system is fueled by misguided policies that drive up costs, and how free-market reforms would steer us toward...
Watch Dr. Wayne Winegarden, director of PRI's Center for Medical Economics and Innovation, discuss the potential savings inherent in biosimilars at the World Biosimilars Conference 2020, held at the Festival of Biologics USA in San Diego. https://youtu.be/XXBVzPa8tMc...
Title: As U.S. Sees COVID-19 Infections Spike, Some Worry About 'Grave Errors' By Adam Smith In the beginning, the few reports of a newly discovered virus seemed inconsequential and distant. The coronavirus was causing pneumonia in scores of people, but those patients were in a faraway province of China, Hubei, that most outside that nation had never heard of. “There is no evidence that the new virus is readily spread by humans, which would make it particularly dangerous, and it has not been...
The Green New Dealers want us to think we have to either live more austere lives under coercive government policies or destroy the planet. Opponents of their plan, the theory goes, are willing to sacrifice the environment for short-term financial prosperity for the elite few. Nothing could be further from the truth. Meeting Americans’ needs, especially those of the neediest, requires free markets that can realize and reward the benefits of technological innovations, big and small. Big innovations are those such as the...
CDC warns on coronavirus in US: Should you start to worry? By Madeline Farber, Fox News Federal health officials this week warned that community spread of the novel coronavirus in the U.S. is seemingly inevitable, with one Centers for Disease Control and Prevention (CDC) official saying it’s no longer “a question of if, but when, and how many people in this country will have severe illness.” In the same vein, officials have maintained that the immediate threat to the public remains low. So how worried should you be?...
WHO says coronavirus ‘absolutely’ has potential for pandemic status as Italy, Iran brace for surge By: Alexandria Hein Health officials stressed on Monday that while Iran and Italy have reported a surge in coronavirus cases over the last several days and raced to cancel public events, the outbreak, which originated in China, has not yet met the criteria for a pandemic, although it “absolutely” has the potential to get there. “Using the term pandemic now, it doesn’t fit the facts, but it may...
Business impact widens as China fights to get infections under control By: Anjalee Khemlani, Yahoo! Finance Feb. 7, 2020 China’s deadly coronavirus outbreak continues to threaten multi-national companies, as a range of businesses from leisure to retail suffer from the outbreak’s after-effects. The number of confirmed cases in the country surged past 31,000 Friday, well beyond three times the number of cases last week. While the number of new cases daily have dipped slightly, World Health Organization officials said on Friday the organization’s not...
https://www.youtube.com/watch?v=so744sbVJ_E Dr. Henry Miller, senior fellow with PRI’s Center for Medical Economics and Innovation, joins PRI's "Next Round" podcast to discuss the Wuhan Coronavirus. We explore a wide variety of topics related to this public health crisis, including how people get the illness and how it is being treated, how the Chinese and U.S. governments are working to combat it, the prospects for the rapid development of a vaccine, how social media disinformation is fueling the crisis, and how concerned Americans...